A population-based case-control study of the tumor necrosis factor alpha-308 polymorphism in multiple sclerosis
Dean M. Wingerchuk(WinnMed), Brian G. Weinshenker(Mayo Clinic in Arizona), Janet L. Sobell(Mayo Clinic), Qihan Liu(Mayo Clinic), Sebastian-Patrick Sommer(Mayo Clinic)
Cited by 54
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k